• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Turkish Parliament Legalizes Medical Cannabis Sales

ANKARA – In a pivotal decision, the Turkish Parliament has passed a groundbreaking law establishing the controlled sale of low-THC medical cannabis products in licensed pharmacies, representing a transformative shift in the nation's healthcare system. ...

Psilocybin Law Reforms Gain Momentum Across the United States

LOS ANGELES- Efforts to reform psilocybin laws are accelerating nationwide, with several states making significant strides toward decriminalization or legalization of the psychoactive compound found in "magic mushrooms."​ In Colorado, voters approved Proposition 122 in ...

  • Global Medical Marijuana Market

MediPharm Labs Reports 27% Annual Revenue Growth

LOS ANGELES- MediPharm Labs Corp., a pharmaceutical company specializing in precision-based cannabinoids, has announced a 27% increase in annual net revenue for 2024, reaching $42 million. This growth is primarily attributed to a significant rise ...

Lucid Green Inc. Secures $3.1MM Funding

NEW YORK–Lucid Green Inc., today announced funding of $3.1MM from new investors, Bravos Capital, Silverleaf Ventures, and existing investors FGCP and HALLEY Venture Partners. This funding will be utilized to further the adoption of LucidIDs ...

Supreme Cannabis Announces Financial Results for Q3 2021

TORONTO–Supreme Cannabis (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced its financial and operating results for the three months ended March 31, 2021.   Supreme Cannabis' Management Discussion & Analysis ("MD&A") and condensed interim consolidated ...

Charlotte’s Web Holdings Reports Quarter 1 2021 Results

BOULDER– Charlotte's Web Holdings (TSX: CWEB) (OTCQX: CWBHF), Charlotte's Web Holdings, Inc. the market share leader in full spectrum cannabidiol (CBD) hemp extract wellness products, today reported financial results for the first quarter ended March ...

Cardiol Therapeutics Closes $22 Million Bought Deal Offering

ONTARIO–Cardiol Therapeutics Inc. (TSX: CRDL), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, is pleased to announce the closing of its previously announced "bought deal" short form prospectus ...

Aleafia Health Reports 2021 First Quarter Results

TORONTO–Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) reported its financial results for the three months ended March 31, 2021. “This quarter saw us achieve important executional breakthroughs as we realized the exponential increase of our ...

Subscribe To Our Newsletter

Go to Top